A meta-analysis to determine the relationship between metabolic syndrome and risk of stroke and mortality


  • Metabolic syndrome (MetS) and some of its components are associated with increased risk of recurrent stroke; MetS is also associated with increased risk of mortality, but no individual component impacted mortality risk.

Why this matters

    It is unclear whether the presence of MetS predicts stroke recurrence or mortality risk. Results from this study support the need for early intervention in patients with MetS to prevent stroke recurrence and reduce mortality risk.